Information & Referral

If you have come to our site seeking information, guidance, or referral services for yourself or another person, you have come to the right place. Wellspring is here to provide education and support to those who need assistance confronting the disease of alcoholism and drug dependence.

Information & Referral

addiction-treatment
Treatment Referrals
Suffering from an addiction problem? We can help you find a treatment facility. You can either browse through our local Treatment Directory, allow us to make suggested referrals by using our self-administered Screening Tool, or if you prefer speaking with one of our professionals, call our confidential Referral Helpline. We are available Monday through Friday from 8 a.m. to 9 p.m. You can also contact us via email at mail@wellspringprevention.org. While not intended to diagnose a substance abuse problem, each of these options will help narrow your search for a program that best meets your needs. Note that the options provided do not represent an exhaustive list of all available programs or constitute an endorsement of particular programs. However, these are programs we have worked with and have consistently received positive feedback from those who have accessed their services. If you live outside of Middlesex County New Jersey, you can get help now by calling the New Jersey Addiction Services Hotline anytime at 844-276-2777. You can also access the New Jersey Mental Health Cares Information and Referral Helpline at 1-866-202-HELP (4357).
If you live outside of New Jersey, reach out to the National Council on Alcoholism and Drug Dependence at www.ncadd.org or 212-269-7797 to find your nearest local resources.
jason-surks-memorial
Jason Surks Memorial Resource Center
The Jason Surks Memorial Prevention Resource Center at Wellspring serves as a clearinghouse for free information about alcohol, tobacco and other drugs. Explore our vast collection of online information and helpful links, or visit us at our East Brunswick, NJ location to access free pamphlets, posters and DVD lending library.
More than just a physical and web-based library, our Resource Center is people. If you need assistance planning an educational program, need information for a health fair, or would like to contract with our staff to provide presentations in your community, please call us at 732-254-3344 or send us an email request at info@wellspringprevention.org.

Extended-Release Naltrexone Leads to Lower Rate of Opioid Relapse

image Extended-release naltrexone is associated with a much lower rate of heroin relapse in men who have been released from jail, compared with released inmates addicted to heroin who are not given treatment, a new study concludes.

Extended-release naltrexone, sold under the brand name Vivitrol, blocks the effects of opioids such as heroin on the brain, Forbes reports.

Vivitrol prevents relapse by reducing euphoria, pain relief, sedation, physical dependence and cravings. It is given as a monthly injection.

The study included 33 men who had been incarcerated by the New York City Department of Corrections. They did not want to participate in methadone or buprenorphine maintenance programs. Sixteen of the men received Vivitrol before they were released from jail, and were offered a second injection a month later. The other 17 inmates did not receive the drug.

Among those not given Vivitrol, 88 percent relapsed after being out of jail for a month, compared with 38 percent of those given the drug, the researchers report in Addiction.

Vivitrol can be expensive, the article notes. The retail cost is about $1,100 per dose. People with insurance coverage usually have a co-pay of up to $50 per dose. Medicaid costs for the drug vary depending on state plans.

"There has been a lot of interest in Vivitrol as post-incarceration relapse prevention, but not much actual data," lead investigator Joshua Lee noted in a news release. "This randomized trial was designed to examine the impact of the medication on relapse to heroin in the first few weeks after release from jail, and it showed substantial benefits."

Log in

fb iconLog in with Facebook
create an account